Surgical approach to hysterectomy for benign gynaecological disease
Information
- DOI:
- https://doi.org/10.1002/14651858.CD003677.pub6Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 29 August 2023see what's new
- Type:
-
- Intervention
- Stage:
-
- Review
- Cochrane Editorial Group:
-
Cochrane Gynaecology and Fertility Group
- Copyright:
-
- Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
Charlotte Pickett: extracted data for the current update, assisted with data entry and analysis, and wrote the current update.
Dachel Seeratan: assisted with data extraction and data entry, and wrote the current update.
Tijmen Bonestroo: study selection and data extraction for the current update, assisted with data entry and analysis, wrote the current update.
Theodoor E Nieboer: assisted with data extraction and interpretation, commented on the current update.
Neil Johnson: conceptualised the first review, wrote the protocol and the review, helped supervise the selection of trials and data extraction, and commented on the current update.
Ben Willem Mol: assisted with data extraction and interpretation, commented on the current update.
Johanna WM Aarts: selected trials and extracted data for the current update, performed data entry, wrote and supervised the current update of the review.
Sources of support
Internal sources
-
No internal source of support, Other
None
External sources
-
No external source of support, Other
None
Declarations of interest
Charlotte Pickett has no declarations of interest.
Dachel Seeratan has no declarations of interest.
Tijmen Bonestroo has no declarations of interest.
Theodoor E Nieboer has no declarations of interest.
Neil Johnson is a fiduciary officer of World Endometriosis Society and Asia Pacific Initiative in Reproduction (ASPIRE); has received financial remuneration for consultancies from Myovant Sciences and Roche Diagnostics GmbH; and has received research funding from Guerbet and Abbott Pharmaceuticals.
Ben Willem Mol has received financial remuneration for consultancies from Merck, Guerbet LLC and ObcEva.
Johanna WM Aarts has no declarations of interest.
Acknowledgements
We thank David Barlow, who was involved in the accomplishment of the protocol and the first review, for all his work. We thank Mrs Anne Lethaby, Auckland who commented on the protocol, and assisted with selection of trials, data extraction and data entry in the first review.
We thank the following people for their contributions to previous versions of this review: Jane Clarke, the former Managing Editor of the Cochrane Menstrual Disorders and Subfertility Group, New Zealand; Sabine van Voorst, the Netherlands; Elisabeth Curr, New Zealand.
The authors of the 2023 update thank Emma Tavender, Ray Garry and Kirsten Kluivers for their contributions to previous versions of this review. We thank the current Managing Editor of Cochrane Gynaecology and Fertility, Helen Nagels. We thank Information Specialist Marian Showell for her assistance with the literature search. We thank our peer reviewers Professor Chris Maher and Dr Jack Wilkinson, and external editors. We thank also Jenny Bellorini, Cochrane Central Production Service, who copy edited our draft.
Version history
| Published | Title | Stage | Authors | Version |
| 2023 Aug 29 | Surgical approach to hysterectomy for benign gynaecological disease | Review | Charlotte M Pickett, Dachel D Seeratan, Ben Willem J Mol, Theodoor E. Nieboer, Neil Johnson, Tijmen Bonestroo, Johanna WM Aarts | |
| 2015 Aug 12 | Surgical approach to hysterectomy for benign gynaecological disease | Review | Johanna WM Aarts, Theodoor E Nieboer, Neil Johnson, Emma Tavender, Ray Garry, Ben Willem J Mol, Kirsten B Kluivers | |
| 2009 Jul 08 | Surgical approach to hysterectomy for benign gynaecological disease | Review | Theodoor E Nieboer, Neil Johnson, Anne Lethaby, Emma Tavender, Elizabeth Curr, Ray Garry, Sabine van Voorst, Ben Willem J Mol, Kirsten B Kluivers | |
| 2006 Apr 19 | Surgical approach to hysterectomy for benign gynaecological disease | Review | Theodoor E Nieboer, Neil Johnson, David Barlow, Anne Lethaby, Emma Tavender, Elizabeth Curr, Ray Garry, Sabine van Voorst, Ben Willem J Mol, Kirsten Kluivers | |
| 2005 Jan 24 | Surgical approach to hysterectomy for benign gynaecological disease | Review | Neil Johnson, David Barlow, Anne Lethaby, Emma Tavender, Elizabeth Curr, Ray Garry | |
| 2002 Apr 22 | Surgical approaches to hysterectomy for benign gynaecological disease | Protocol | Neil NP Johnson, Anne Lethaby, Cindy M Farquhar, Ray Garry, David Barlow | |
Differences between protocol and review
There are now various differences between the protocol (published in 2002) and this version of the review:
-
New types of hysterectomy have been added. These include single‐port laparoscopic hysterectomy, robot‐assisted hysterectomy and V‐NOTES hysterectomy.
-
While not included in the original protocol, we have excluded two types of hysterectomy included in the prior published review, as we no longer consider mini‐laparoscopic hysterectomy and mini‐laparotomy different from LH or AH respectively.
-
Haemoglobin or haematocrit drop and "other intraoperative complication" have been removed from the list of secondary outcomes.
-
The outcomes in the summary of findings (SOF) tables have been edited for clinical relevance. They now include our primary outcomes and three of our secondary outcomes (vaginal cuff infection, wound/abdominal wall infection and febrile episodes). We no longer report vascular injury, bowel injury, bleeding or unintended laparotomy in the SOF tables.
